Product Code: CHNZ
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2020-2021
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Labelling on paracetamol to be updated
GSK Consumer Healthcare extends its lead, benefiting from selling the most trusted paracetamol product as the pandemic continues
Chemists/pharmacies gaining value share during pandemic
PROSPECTS AND OPPORTUNITIES
Social behaviour changed by COVID-19
Ageing population leads to value growth
Analgesics innovate through further segmentation
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Subdued value growth, as social restriction measures curb spread of common cold
Multinational continue to dominate
Consumers look for natural, home-made remedies
PROSPECTS AND OPPORTUNITIES
Post pandemic, product area will recover
Immune-boosting properties remain popular
Antihistamines/allergy remedies see further growth
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Growing prevalence of gastro-oesophageal reflux disease (GORD) increases need for digestive remedies
Reckitt Benckiser leads digestive remedies, as Apotex stops supplying heartburn medication to New Zealand
Increased marketing efforts of unhealthy foods during the pandemic continued to feed demand of digestive remedies
PROSPECTS AND OPPORTUNITIES
Healthier eating could dampen growth rates over forecast period
Probiotics and fibre supplements growing threat
Paediatric digestive remedies negatively impacts value growth
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 impacts dermatologicals in a variety of ways
Multinationals continue to dominate, but local player Multichem gains value share
Medsafe's approval for mometansone furoate increases value growth for antipruritics
PROSPECTS AND OPPORTUNITIES
Demographics drive value growth of dermatologicals over forecast period
Love of outdoors is expected to drive demand for topical allergy remedies/antihistamines
Social stigma of certain products benefits online sales
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 ignited motivation among more smokers to quit
Nicorette from Johnson & Johnson leads, as players offer kits and plans to support consumers trying to quit smoking
New support for smokers slows growth of NRT smoking cessation
PROSPECTS AND OPPORTUNITIES
Minimal growth of NRT smoking cessation due to government initiatives
Negative publicity surrounding vaping positively impacts NRT smoking cessation aids
COVID-19 puts health in the spotlight
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 exacerbated consumers sleep disorders
Local player, Sleep Drops, continues to dominate
Sleep aids benefits from melatonin switch from schedule 4 to schedule 3 for qualified demographic
PROSPECTS AND OPPORTUNITIES
Greater acceptance of sleep aids leads to value growth
Ageing population rives value sales
Alternatives dampen value sales
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Increased screen time leads to increased tired eyes
Clear Eyes continues to lead the landscape; however, Optrex records the highest growth, providing innovation to consumers
Pandemic also gives allergy eye car a boost
PROSPECTS AND OPPORTUNITIES
Outlook very positive over forecast period
Standard eye care set to be boosted by the ageing population
Allergy eye care is expected to see stable growth due to climate change impacting the pollution
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Consumer return to pre-pandemic activities increases growth of wound care
Private label gains value share in 2021
Pricing main driver of value sales
PROSPECTS AND OPPORTUNITIES
Post-COVID health trend with consumers to desire to keep active likely to support demand, however, maturity of wound care limits major growth
Innovation needed to stand out from competition
Elderly workforce will continue to drive value sales of wound care
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Flurry of NPD as players look to benefit from boon of vitamins
Berocca continues to lead the product landscape
Vitamins cross over boundaries with other products
PROSPECTS AND OPPORTUNITIES
Increasing competition from fortifying trend in food sector
Innovation in formats over forecast period
Increasing segmentation over forecast period
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Pandemic see surge in demand for immune boosting dietary supplements
USANA Health Science performs strongly in 2021
Flurry of NPD and start-ups within dietary supplements
PROSPECTS AND OPPORTUNITIES
Benefits rather ingredients drive value sales over forecast period
Holistic approach to health drives value sales
More targeted solutions over forecast period
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Slimming teas under the spotlight
Vitamins and dietary supplements players lead
Meal replacement products suffer as home cooking increases
PROSPECTS AND OPPORTUNITIES
New product development will align to health food trends to stay relevant to consumers
Rise in ageing population will contribute to growth in demand of supplement nutrition drinks
Outlook bleak for OTC Obesity
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Sports nutrition enters the mainstream
Local player Vitaco continues to lead
Clean and plant-based trends enter sports nutrition
PROSPECTS AND OPPORTUNITIES
Rosy outlook over forecast period
Blurring of boundaries continues
Growth supported by health and wellness trend
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Herbal/traditional products unaffected by pandemic
Domestic players attract consumers through the use of locally sourced ingredients
Reclassification of plant extract to prescription-only medicine
PROSPECTS AND OPPORTUNITIES
Tightening of regulations expected to slow growth in the future
Changes in how people interact dampen value sales of cough and cold remedies
Herbal/traditional digestive remedies challenged innovation in dietary supplements
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN NEW ZEALAND
KEY DATA FINDINGS
2021 DEVELOPMENTS
Stockpiling trend eases in 2021
Sales are led by paediatric vitamins and dietary supplements
Players focus on child-friendly design
PROSPECTS AND OPPORTUNITIES
Demand for immune-boosting paediatric products wane
Shift towards natural products over forecast period
Declining birth rate dampens value sales
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
